Safety and efficacy of GP40061 compared with originator insulin glargine (Lantus ®): a randomized open-label clinical trial.

Conclusion: GP-Gla and Sa-Gla demonstrated similar safety and efficacy. ClinicalTrials.gov Identifier: NCT04022993. PMID: 32027167 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research